Upregulation of MicroRNA-34a Sensitizes Ovarian Cancer Cells to Resveratrol by Targeting Bcl-2.
Shangli YaoMing GaoZujun WangWenyan WangLei ZhanBing WeiPublished in: Yonsei medical journal (2021)
Overall, these results demonstrated that REV exerts anti-cancer effects on OC cells through an miR-34a/Bcl-2 axis, highlighting the therapeutic potential of REV for treatment of OC.